Inhalation device options for the management of chronic obstructive pulmonary disease

Postgrad Med. 2018 Jan;130(1):83-97. doi: 10.1080/00325481.2018.1399042. Epub 2017 Dec 5.

Abstract

Chronic obstructive pulmonary disease (COPD) is characterized by chronic respiratory symptoms and airflow limitation, resulting from abnormalities in the airway and/or damage to the alveoli. Primary care physicians manage the healthcare of a large proportion of patients with COPD. In addition to determining the most appropriate medication regimen, which usually includes inhaled bronchodilators with or without inhaled corticosteroids, physicians are charged with optimizing inhalation device selection to facilitate effective drug delivery and patient adherence. The large variety of inhalation devices currently available present numerous challenges for physicians that include: (1) gaining knowledge of and proficiency with operating different device classes; (2) identifying the most appropriate inhalation device for the patient; and (3) providing the necessary education and training for patients on device use. This review provides an overview of the inhalation device types currently available in the United States for delivery of COPD medications, including information on their successful operation and respective advantages and disadvantages, factors to consider in matching a device to an individual patient, the need for device training for patients and physicians, and guidance for improving treatment adherence. Finally, the review will discuss established and novel tools and technology that may aid physicians in improving education and promoting better adherence to therapy.

Keywords: Inhaler; adherence; chronic obstructive pulmonary disease; dry powder inhaler; nebulizer; pressurized metered-dose inhaler; soft mist inhaler.

Publication types

  • Review

MeSH terms

  • Administration, Inhalation
  • Age Factors
  • Bronchodilator Agents / administration & dosage*
  • Glucocorticoids / administration & dosage*
  • Humans
  • Medication Adherence
  • Nebulizers and Vaporizers*
  • Patient Selection
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • United States

Substances

  • Bronchodilator Agents
  • Glucocorticoids